Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Tocilizumab as monotherapy or combination therapy for treating active rheumatoid arthritis: a meta-analysis of efficacy and safety reported in randomized controlled trials

Fig. 2

Forest plots of Disease Activity Score remission (<2.6) assessed in 28 joints (DAS28) comparing tocilizumab combination therapy (TCZ COMBI ) with tocilizumab monotherapy (TCZ MONO ) (a), TCZCOMBI with a conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) (b) and TCZMONO with a csDMARD (c)

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us